PA83-FhCMB Plant-Derived Recombinant Protective Antigen (rPA) Anthrax Vaccine
NCT02239172
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Anthrax
Interventions
BIOLOGICAL:
PA83-FhCMB
Sponsor
Fraunhofer, Center for Molecular Biotechnology